Related references
Note: Only part of the references are listed.Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases
Lun Li et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
The roles of microglia in viral encephalitis: from sensome to therapeutic targeting
Chintan Chhatbar et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Immune Regulation of Adult Neurogenic Niches in Health and Disease
Sana Chintamen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Viral infections and their relationship to neurological disorders
Jessica Wouk et al.
ARCHIVES OF VIROLOGY (2021)
Material properties of bighorn sheep (Ovis canadensis) horncore bone with implications for energy absorption during impacts
Luca H. Fuller et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2021)
Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains
Yaxing Gui et al.
BRAIN PATHOLOGY (2020)
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
Frederic Brosseron et al.
ALZHEIMERS & DEMENTIA (2020)
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review
Kirsten E. J. Wesenhagen et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid
Boris-Stephan Rauchmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
William J. Meilandt et al.
JOURNAL OF NEUROSCIENCE (2020)
Biological functions and therapeutic opportunities of soluble cytokine receptors
Juliane Lokau et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2020)
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
Shorena Janelidze et al.
NATURE COMMUNICATIONS (2020)
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease
Maotian Zhou et al.
CLINICAL PROTEOMICS (2020)
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
Erik C. B. Johnson et al.
NATURE MEDICINE (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model
Shoutang Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration
Maud Gratuze et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cytosolic DNA Sensors and CNS Responses to Viral Pathogens
Austin M. Jeffries et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
CNS Macrophages and Infant Infections
Alexander Oschwald et al.
FRONTIERS IN IMMUNOLOGY (2020)
Porphyromonas gingivalis is a Strong Risk Factor for Alzheimer's Disease
Shalini Kanagasingam et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review
Jong-Chan Park et al.
BMB REPORTS (2020)
Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease
Edward J. Goetzl et al.
FASEB JOURNAL (2019)
The Cross-sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging
Alexandra M. V. Wennberg et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Glial activation and inflammation along the Alzheimer's disease continuum
Kaja Nordengen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Increases in a Pro-inflammatory Chemokine, MCP-1, Are Related to Decreases in Memory Over Time
Brianne M. Bettcher et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Inflammatory biomarkers in Alzheimer's disease plasma
Angharad R. Morgan et al.
ALZHEIMERS & DEMENTIA (2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleo et al.
ALZHEIMERS & DEMENTIA (2019)
Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges
Seongju Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
Jorge L. Del-Aguila et al.
MOLECULAR NEURODEGENERATION (2019)
Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke
Camilla Thygesen et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
Aliza P. Wingo et al.
NATURE COMMUNICATIONS (2019)
Towards a unified protocol for handling of CSF before β-amyloid measurements
Shorena Janelidze et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology
Pierre-Francois Meyer et al.
ALZHEIMERS & DEMENTIA (2019)
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease
Delphine Boche et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease
Michael Ewers et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?
Milica Cerovic et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease
Christopher D. Whelan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis
Steven Bradburn et al.
AGEING RESEARCH REVIEWS (2019)
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis
Kunal Dhiman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword
Teresa Trotta et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis
Pierre-Francois Meyer et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage
Brianne M. Bettcher et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease
Bianca A. Trombetta et al.
PLOS ONE (2018)
Tau accumulations in the brains of woodpeckers
George Farah et al.
PLOS ONE (2018)
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
Wei-Ju Lee et al.
SCIENTIFIC REPORTS (2018)
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease
Frederic Brosseron et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
TREM2-a key player in microglial biology and Alzheimer disease
Tyler K. Ulland et al.
NATURE REVIEWS NEUROLOGY (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis
Dan Liu et al.
NEUROSCIENCE LETTERS (2018)
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy
Faten A. Sayed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Xi Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection (vol 99, pg 56, 2018)
William A. Eimer et al.
NEURON (2018)
Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer's Disease
Ruth F. Itzhaki
FRONTIERS IN AGING NEUROSCIENCE (2018)
TREM2 expression in the human brain: a marker of monocyte recruitment?
Marie Fahrenhold et al.
BRAIN PATHOLOGY (2018)
Cerebrospinal fluid circulation: What do we know and how do we know it?
Ahmad H. Khasawneh et al.
BRAIN CIRCULATION (2018)
TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
Honghua Zheng et al.
JOURNAL OF NEUROSCIENCE (2017)
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
Shane M. Bemiller et al.
MOLECULAR NEURODEGENERATION (2017)
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Per Johansson et al.
PLOS ONE (2017)
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T. Harach et al.
SCIENTIFIC REPORTS (2017)
Gut microbiome alterations in Alzheimer's disease
Nicholas M. Vogt et al.
SCIENTIFIC REPORTS (2017)
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology
Jean-Vianney Haure-Mirande et al.
ACTA NEUROPATHOLOGICA (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio et al.
ACTA NEUROPATHOLOGICA (2016)
Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging
Lorraine Hamelin et al.
BRAIN (2016)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2016)
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Taylor R. Jay et al.
JOURNAL OF NEUROSCIENCE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
Kristi Henjum et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments
Henrik Zetterberg
CURRENT OPINION IN PSYCHIATRY (2015)
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Kangyun Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
Taylor R. Jay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice
Teng Jiang et al.
NEUROBIOLOGY OF AGING (2015)
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge
David M. Cash et al.
NEUROIMAGE (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging
Adam D. Bachstetter et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Link Between Chronic Bacterial Inflammation and Alzheimer Disease
Fehmida Bibi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Human CNS immune senescence and neurodegeneration
Wolfgang J. Streit et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Role of Clusterin in Amyloid-β-Associated Neurodegeneration
Rahul S. Desikan et al.
JAMA NEUROLOGY (2014)
Interleukin 6 Plasma Concentration Associates with Cognitive Decline: The Northern Manhattan Study
Alexis Economos et al.
NEUROEPIDEMIOLOGY (2013)
Review: Experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology
D. C. Lee et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
R. Tarawneh et al.
NEUROLOGY (2012)
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
Karin Westin et al.
PLOS ONE (2012)
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
The injured nervous system: A Darwinian perspective
Zachary M. Weil et al.
PROGRESS IN NEUROBIOLOGY (2008)
Longitudinal stability of CSF biomarkers in Alzheimer's disease
Kaj Blennow et al.
NEUROSCIENCE LETTERS (2007)
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease
D Galimberti et al.
ARCHIVES OF NEUROLOGY (2006)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease
YX Sun et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
A randomized controlled trial of prednisone in Alzheimer's disease
PS Aisen et al.
NEUROLOGY (2000)
Share Paper
